Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Mebendazole
Drug ID BADD_D01353
Description A benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules. [PubChem]
Indications and Usage For the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.
Marketing Status Prescription; Discontinued
ATC Code P02CA01
DrugBank ID DB00643
KEGG ID D00368
MeSH ID D008463
PubChem ID 4030
TTD Drug ID D0J1MI
NDC Product Code 49452-4395; 59285-011; 64896-669; 73309-120; 50458-675; 12578-618; 53104-7510; 69766-038; 90027-001
Synonyms Mebendazole | Vermidil | Wormkuur | Anti-Worm | Anti Worm | Bantenol | Banworm | Boots Threadworm Treatment | Lomper | Madicure | Mebendan | Mebenvet | Pripsen Mebendazole | R17635 | Sqworm | Sufil | Telmin | Vermicol | Surfont | Vermox
Chemical Information
Molecular Formula C16H13N3O3
CAS Registry Number 31431-39-7
SMILES COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.0020.168360%
Abdominal pain upper07.01.05.0030.024051%
Abortion spontaneous18.01.04.0010.024051%Not Available
Agranulocytosis01.02.03.001--Not Available
Alanine aminotransferase increased13.03.01.003--
Anal atresia07.13.05.001; 03.04.06.0010.024051%Not Available
Angioedema23.04.01.001; 10.01.05.0090.024051%Not Available
Aspartate aminotransferase increased13.03.01.006--
Asthenia08.01.01.0010.024051%Not Available
Conjunctivitis11.01.06.012; 06.04.01.0020.024051%
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.0010.072154%
Dizziness17.02.05.003; 24.06.02.007; 02.01.02.0040.144308%
Dyspnoea22.02.01.004; 02.01.03.0020.024051%
Encephalitis17.06.05.001; 11.01.03.0080.024051%
Fatigue08.01.01.0020.048103%
Gamma-glutamyltransferase increased13.03.01.011--
Gastrointestinal disorder07.11.01.0010.024051%Not Available
Gastrointestinal pain07.01.05.005--
Haemangioma congenital24.03.06.005; 16.02.01.004; 03.07.03.0020.048103%Not Available
Headache17.14.01.0010.060129%
Hepatitis09.01.07.004--Not Available
Hepatocellular injury09.01.07.0080.024051%Not Available
Hyperhidrosis23.02.03.004; 08.01.03.0280.024051%
Hypersensitivity10.01.03.003--
Hypospadias21.15.01.003; 20.07.04.001; 03.03.01.0050.036077%Not Available
Malaise08.01.01.0030.024051%
Menorrhagia21.01.03.002--
Muscular weakness17.05.03.005; 15.05.06.0010.096206%
Nausea07.01.07.0010.144308%
The 1th Page    1 2    Next   Last    Total 2 Pages